Jacobson Pharma Corp. Ltd. (2633) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jacobson Pharma Corp. Ltd.

JBM (Healthcare) Ltd.

Why is Jacobson Pharma Corp. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 0.07% and Operating profit at 4.56% over the last 5 years

Flat results in Mar 25

NO KEY NEGATIVE TRIGGERS

With ROE of 13.30%, it has a Fair valuation with a 1.20 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 59.26%, its profits have risen by 50.9% ; the PEG ratio of the company is 0.2

Consistent Returns over the last 3 years

Along with generating 59.26% returns in the last 1 year, the stock has outperformed Hang Seng Hong Kong in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Jacobson Pharma Corp. Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jacobson Pharma Corp. Ltd. for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

Jacobson Pharma Corp. Ltd.

53.57%

2.55

43.68%

Hang Seng Hong Kong

27.36%

1.03

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.07%

EBIT Growth (5y)

4.56%

EBIT to Interest (avg)

6.33

Debt to EBITDA (avg)

1.52

Net Debt to Equity (avg)

0.09

Sales to Capital Employed (avg)

0.43

Tax Ratio

19.50%

Dividend Payout Ratio

59.41%

Pledged Shares

Institutional Holding

ROCE (avg)

8.92%

ROE (avg)

9.37%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.20

EV to EBIT

8.60

EV to EBITDA

6.18

EV to Capital Employed

1.18

EV to Sales

2.01

PEG Ratio

0.18

Dividend Yield

11.84%

ROCE (Latest)

13.75%

ROE (Latest)

13.30%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

ROCE(HY)

Highest at 12.47%

PRE-TAX PROFIT(Q)

Highest at HKD 215.14 MM

DIVIDEND PAYOUT RATIO(Y)

Highest at 68.07%

RAW MATERIAL COST(Y)

Fallen by -7.27% (YoY

DIVIDEND PER SHARE(HY)

Highest at HKD 7.32

OPERATING PROFIT MARGIN(Q)

Highest at 33.24 %

NET PROFIT(Q)

Highest at HKD 174.43 MM

EPS(Q)

Highest at HKD 0.08

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Jacobson Pharma Corp. Ltd.

Pre-Tax Profit

Highest at HKD 215.14 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Operating Profit Margin

Highest at 33.24 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

At HKD 215.14 MM has Grown at 50.11%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit

Highest at HKD 174.43 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS

Highest at HKD 0.08

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Dividend per share

Highest at HKD 7.32

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (HKD)

Dividend Payout Ratio

Highest at 68.07%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -7.27% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jacobson Pharma Corp. Ltd.

Non Operating Income

Highest at HKD 0.27 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income